ClinicalTrials.Veeva

Menu

One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

Glaukos logo

Glaukos

Status

Completed

Conditions

Primary Open Angle Glaucoma (POAG)

Treatments

Device: iStent

Study type

Interventional

Funder types

Industry

Identifiers

NCT01517477
GCF-033

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and efficacy of the intraocular pressure (IOP) lowering effect of one, two, or three iStent devices in eyes of subjects previously on two anti-glaucoma medications.

Enrollment

119 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosed with primary open-angle glaucoma (POAG)
  • Subject on two topical hypotensive medications

Exclusion criteria

  • Traumatic, uveitic, neovascular, or angle closure glaucoma
  • Fellow eye already enrolled

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

119 participants in 3 patient groups

First Arm: One iStent
Experimental group
Description:
Device: One iStent
Treatment:
Device: iStent
Device: iStent
Device: iStent
Second Arm: Two iStents
Experimental group
Description:
Device: Two iStent devices
Treatment:
Device: iStent
Device: iStent
Device: iStent
Third Arm: Three iStents
Experimental group
Description:
Device: Three iStent devices
Treatment:
Device: iStent
Device: iStent
Device: iStent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems